腹水浓缩腹腔回输对顽固性腹水的治疗  

Efficacy of in-vitro Closed Concentration and Reinfusion Treatment in Patients with Liver Cirrhosis and Refractory Ascites

作　　者：史立华[1] 夏青[1] 张其胜[1] 

机构地区：[1]上海市第一人民医院分院消化科,上海200081

出　　处：《中国临床医学》2007年第1期27-28,共2页Chinese Journal of Clinical Medicine

摘　　要：目的:评价体外腹水浓缩腹腔回输对改善顽固性腹水的疗效。方法:选择42例顽固性腹水患者进行腹穿,使腹水经过体外浓缩再回输入腹腔,1个月后比较治疗前后的临床症状评分及生活质量评分,并观察血液生化指标的变化。结果:经过腹水浓缩回输后,临床症状、生活质量均显著改善(P＜0．01)。与治疗前比较,血浆白蛋白在治疗1d、1周后有统计学差异(P＜0．05),1个月后无统计学差异(P＞0．05),总胆红素在治疗后无统计学差异。结论:腹水浓缩回输腹腔治疗顽固性腹水,效果可靠,操作简单,并发症少,有利于提高患者的生活质量。Objective：To evaluate efficacy of patients with liver cirrhosis and refractory ascites treated with in vitro closed concentration and reinfusion. Methods.. Forty-two Patients with refractory ascites were treated with in vitro closed concentration and reinfusion. One months later, the symptom score, life quality score, weight, serum biochemical indexes, were compared before and after treatment. Results： After treatment, the symptom score, life quality were significantly improved. Serum albumin levels were higher on in one day,one week after treatment than that of before treatonent （P〈0.05）. No change could be detected in bilirubin（P〈0.05）. Conclusion：In vitro closed concentration and reinfusion is a very simple and convenient way to relieves symptoms enhances life-quality for patients with liver cirrhosis.

关 键 词：顽固性腹水 浓缩回输 肝硬化 

分 类 号：R575.2[医药卫生—消化系统]